Scholars Central

Conference abstractPublished 29 Jun 2017

Expression profiling of chemokine receptors in peripheral blood mononuclear cells in chronic lymphocytic leukemia

Authors: Gabcova G, Kraiczova V, Manukyan G, Mikulkova Z, Fillerova R, Urbanova R, Turcsanyi P, Ryznarova P, Papajik T, Kriegova E

Palacky University Olomouc, Czech Republic; Institute of Molecular Biology, Armenia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic lymphocytic leukemia (CLL) cell is characterized by a progressive accumulation of long-lived CD5+ B lymphocytes in bone marrow/lymph nodes, whose survival requires exogenous activation signals such as chemokines. Growing number of studies show that chemokines and their receptors, in addition to trafficking, have much broader influence on neoplastic cells, such as cell growth, differentiation and survival. To gain more insights into the chemokine receptor network in CLL, we characterized the expression pattern of 16 canonical and 4 atypical chemokine receptors in peripheral blood mononuclear cells (PBMC) of CLL patients (n=88) and healthy subjects (n=34) by using quantitative RT-PCR. The expression of CXCR3, CXCR4, CXCR5, CXCR7, and CCR7 was confirmed by 6-color flow cytometry. Among deregulated receptors, 5 receptors (CCR7, CCR10, CXCR3, CXCR4, CXCR5) were up-regulated and 9 receptors (CCR2-CCR6, CCR8, CCRL2, CXCR1, CXCR2) down-regulated in CLL; the expression of others did not differ between CLL and controls (P>0.05). We have also analyzed differences in expression pattern in CLL groups subdivided according to cytogenetics (13q and 17q deletions). In patients with del(17q) having worse prognosis, we observed higher mRNA levels of CXCR6, CXCR7 and CCR10 comparing to del(13q) associated with good prognosis. In conclusion, differential expression patterns of chemokine receptors suggest the relevance of the network of these receptors in CLL pathogenesis. The potential of chemokine/chemokine receptor network as determinant for clinical outcome and novel therapies is worth exploring.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Gabcova G”
  • BylineArticles whose byline prints “Kraiczova V”
  • BylineArticles whose byline prints “Manukyan G”
  • BylineArticles whose byline prints “Mikulkova Z”
  • BylineArticles whose byline prints “Fillerova R”
  • BylineArticles whose byline prints “Urbanova R”
  • BylineArticles whose byline prints “Turcsanyi P”
  • BylineArticles whose byline prints “Ryznarova P”